Cargando…
Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy
Standard of care follow-up therapy for patients poisoned by long-acting anticoagulant rodenticides (LAARs) is daily high-dose (up to 100 mg per day) oral vitamin K1 (VK(1)) for weeks to months to over a year. The availability of CLIA-certified quantitative testing for plasma LAAR concentrations can...
Autores principales: | Nosal, Daniel G., van Breemen, Richard B., Haffner, John W., Rubinstein, Israel, Feinstein, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990043/ https://www.ncbi.nlm.nih.gov/pubmed/33768191 http://dx.doi.org/10.1080/24734306.2021.1887637 |
Ejemplares similares
-
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
por: Rubinstein, Israel, et al.
Publicado: (2019) -
Unmet clinical laboratory need in patients hospitalized for acute poisoning from long-acting anticoagulant rodenticides
por: van Breemen, Richard B., et al.
Publicado: (2021) -
Oral administration of injectable vitamin K1 in brodifacoum intoxication
por: Chu, Yen-Jung, et al.
Publicado: (2022) -
Therapeutic plasma exchange: a second‐line treatment for brodifacoum poisoning following an anaphylactoid reaction to vitamin K
por: Deng, Ying, et al.
Publicado: (2016) -
Severe Vitamin K-dependent Coagulopathy from Rodenticide-contaminated Synthetic Cannabinoids: Emergency Department Presentations
por: Wright, Erik, et al.
Publicado: (2021)